Intermolecular Initial Public Offering

Davis Polk advised Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC and Barclays Capital Inc. as joint book-running managers in connection with the initial public offering of 9,650,000 shares of common stock of Intermolecular, Inc. The gross proceeds from the offering were $96.5 million. Intermolecular’s common stock is traded on the Nasdaq Global Select Market under the symbol “IMI.”

Based in San Jose, California, Intermolecular has pioneered a proprietary approach to accelerate research and development, innovation and time-to-market for the semiconductor and clean-energy industries.

The Davis Polk corporate team included partner Alan F. Denenberg and associates Beth Hooten Ruiz and Alex Kardon. Partner Rachel D. Kleinberg and associate Una Au provided tax advice. Counsel Marcie A. Goldstein provided FINRA advice. Counsel Cynthia Akard provided employment advice. Associates Emma Maconick and Daniel Ray provided intellectual property advice. Counsel Loyti Cheng provided environmental advice. Associate Catherine L. Martin provided Investment Company Act advice. Elizabeth J. Gordon was the legal assistant for the transaction. Members of the Davis Polk team are based in the Menlo Park and New York offices.

Scroll to Top